Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan

Genes and Immunity

Volumn 9, Issue 2, 2008, Pages 87-92

  Chen, P L ^a,b   Fann, C S J ^c,d   Chang, C C ^c   Wu, I L ^a   Chiu, W Y ^a   Lin, C Y ^c   Yang, W S ^a,e,f   Chang, T C ^a,f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GUANINE; TYROSINE;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; FAMILY STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; HUMAN CELL; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; LINKAGE (GENETICS); MALE; PEDIGREE; POLYMORPHISM, GENETIC; TAIWAN;

EID: 40449132140     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364445     Document Type: Article

References (34)

1. Weetman AP. Graves' disease. N Engl J Med 2000; 343: 1236-1248.
2. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F et al The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-493.
3. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-243.
4. Hollowell JG, Staehling NW, Flanders, WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988-1994): National Health And Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
5. DeGroot LJ, Quintans J, The causes of autoimmune thyroid disease. Endocr Rev 1989; 10: 537-562.
6. Brix TH, Kyvik KO, Hegedus L. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 1998; 8: 727-734.
7. Vyse TJ, Todd JA. Generic analysis of autoimmune disease. Cell 1996; 85: 311-618.
8. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001; 86: 930-934.
9. Farid NR. Understanding the genetics of autoimmune thyroid disease - still an illusive goal! J Clin Endocrinol Metab 1992; 74: 495A-495B.
10. Vaidya B, Kendall-Taylor P, Pearce SH. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 2002; 87: 5385-5397.
11. Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 2003; 3: 544-556.
12. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 2003; 24: 694-717.
13. Simmonds MJ, Gough SC, Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol 2004; 136: 1-10.
14. Heward JM, Allahabadia A, Carr-Smith J, Daykin J, Cockram CS, Gordon C et al. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol (Oxf) 1998, 49: 331-334.
15. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E et al. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1908; 47: 125-127.
16. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
17. Vaidya B, Imkie H, Perros P, Young ET, Kelly WF, Carr D et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999; 8: 1195-1199.
18. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999; 84: 2398-2401.
19. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36: 388-393.
20. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361: 598-604.
21. Schulze TG, McMahon FJ. Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am J Med Genet 2002; 114: 1-11.
22. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
24. Ramirez-Soriano A, Lao O, Soldevila M, Calafell F, Bertranpetit J, Comas D. Haplotype tagging efficiency in worldwide populations in CTLA4 gene. Genes Immun 2005; 6: 646-657.
25. Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: A highly significant association with a determinant in the promoter region. Hum Genet 2002; 111: 452-455.
26. Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum 2004; 50: 328-329.
27. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80: 41-45.
28. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997; 46: 551-554.
29. Chang YP, Liu X, Kim JD, Ikeda MA, Layton MR, Weder AB et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet 2007; 80: 253-264.
30. Consortium TIH. The International HapMap Project. Nature 2003; 426: 789-796.
31. Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY et al. Linkage of Graves' disease to the human leucocyte antigen region in the Chinese-Han population in Taiwan. Clin Endocrinol (Oxf) 2007; 66: 646-651.
32. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, Carr-Smith J et al. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 2005; 76: 157-163.
33. Yang WS, Yang YC, Chen CL, Wu IL, Lu JY, Lu FH et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 2007; 86: 509-513.
34. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.